Stability of serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1)

References

• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–137. doi: 10.1053/j.semperi.2009.02.010.
   PubMed Web of Science ®Google Scholar
• Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5(1):173–192. doi: 10.1146/annurev-pathol-121808-102149.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Jung E, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022;226(2S):S786–S803. doi: 10.1016/j.ajog.2021.12.001.
   PubMedGoogle Scholar
• Wikström AK, Larsson A, Eriksson UJ, et al. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol. 2007;109(6):1368–1374. doi: 10.1097/01.AOG.0000264552.85436.a1.
   PubMed Web of Science ®Google Scholar
• Poon LC, Shennan A, Hyett JA, et al. The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(Suppl. 1):1–33. doi: 10.1002/ijgo.12802.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613–622. doi: 10.1056/NEJMoa1704559.
   PubMed Web of Science ®Google Scholar
• NICE (National Institute for Health and Care Excellence). PlGF-based testing to help diagnose suspected pre-eclampsia. Diagnosis guidance 23; 2022 [cited 2022 May 15]. Available from: https://www.nice.org.uk/guidance/dg23
   Google Scholar
• Murphy BM, Swarts S, Mueller BM, et al. Protein instability following transport or storage on dry ice. Nat Methods. 2013;10(4):278–279. doi: 10.1038/nmeth.2409.
   PubMed Web of Science ®Google Scholar
• Trondsetås L, Mikkelsen G, Lian IA. The effects of dry ice exposure on plasma pH and coagulation analyses. Clin Chem Lab Med. 2017;56(1):59–64. doi: 10.1515/cclm-2017-0263.
   PubMed Web of Science ®Google Scholar
• Armstrong-Buisseret LK, Haslam S, James T, et al. Verification of placental growth factor and soluble-fms-like tyrosine kinase 1 assay performance in late pregnancy and their diagnostic test accuracy in women with reduced fetal movement. Ann Clin Biochem. 2020;57(3):223–233. doi: 10.1177/0004563220911993.
   PubMed Web of Science ®Google Scholar
• Cowans NJ, Alfthan H, Stenman UH, et al. Stability of first trimester placental growth factor in serum and whole blood. Prenat Diagn. 2011;31(12):1193–1197. doi: 10.1002/pd.2894.
   PubMed Web of Science ®Google Scholar
• Rowson S, Reddy M, Rolnik DL, et al. Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma. Placenta. 2019;86:1–3. doi: 10.1016/j.placenta.2019.08.001.
   PubMed Web of Science ®Google Scholar
• Thermo Fisher Scientific. BRAHMS PlGF plus Kryptor. Product insert. Hennigsdorf: Thermo Fisher Scientific GmbH; 2018.
   Google Scholar
• Perkin Elmer PlGF application note. Waltham: Perkin Elmer; 2011 [cited 2022 Jun 2]. Available from: https://resources.perkinelmer.com/corporate/pdfs/downloads/samplestabilityofplgf.pdf
   Google Scholar
• Roche Diagnostics. Elecsys PlGF cobas. Product insert. Mannheim: Roche Diagnostics GmbH; 2020.
   Google Scholar
• Thermo Fisher Scientific. BRAHMS sFlt-1Kryptor. Product insert. Hennigsdorf: Thermo Fisher Scientific GmbH; 2018.
   Google Scholar
• Thermo Fisher Scientific. Prenatal screening – compendium. Analytes – PlGF, s-Flt-1, PAPP-A, free ßhCG, AFP. Handling, stability, storage. Hennigsdorf: Thermo Fisher Scientific GmbH; 2021.
   Google Scholar
• Roche Diagnostics. Elecsys sFlt-1 cobas. Product insert. Mannheim: Roche Diagnostics GmbH; 2021.
   Google Scholar
• Noklus; 2022 [cited 2022 Oct 15]. Available from: https://www.noklus.no/helsepersonell-sykehus-ogprivatelaboratorier/holdbarhets­database/utfore-holdbarhetsforsok/
   Google Scholar
• Gomez-Rioja R, Von Meyer A, Cornes M, et al. Recommendation for the design of stability studies on clinical specimens. Clin Chem Lab Med. 2023;61(10):1708–1718. doi: 10.1515/cclm-2023-0221.
   PubMed Web of Science ®Google Scholar
• Gowans EM, Hyltoft Petersen P, Blaabjerg O, et al. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest. 1988;48(8):757–764. doi: 10.3109/00365518809088757.
   PubMed Web of Science ®Google Scholar
• Hirashima C, Ohkuchi A, Arai F, et al. Establishing reference values for both total soluble fms-like tyrosine kinase 1 and free placental growth factor in pregnant women. Hypertens Res. 2005;28(9):727–732. doi: 10.1291/hypres.28.727.
   PubMed Web of Science ®Google Scholar
• Hyltoft Petersen P, Gowans EM, Blaabjerg O, et al. Analytical goals for the estimation of non-Gaussian reference intervals. Scand J Clin Lab Invest. 1989;49(8):727–737. doi: 10.3109/00365518909091551.
   PubMed Web of Science ®Google Scholar
• Åsberg A, Lian IA, Mikkelsen G. TSH: biased estimate of allowable bias. Clin Chem Lab Med. 2022;60(11):e241–e242. doi: 10.1515/cclm-2022-0791.
   PubMed Web of Science ®Google Scholar
• Andersen LLT, Helt A, Sperling L, et al. Decision threshold for Kryptor sFlt-1/PlGF ratio in women with suspected preeclampsia: retrospective study in a routine clinical setting. J Am Heart Assoc. 2021;10(17):e021376.
   PubMed Web of Science ®Google Scholar
• Albert A. On the use and computation of likelihood ratios in clinical chemistry. Clin Chem. 1982;28(5):1113–1119. doi: 10.1093/clinchem/28.5.1113.
   PubMed Web of Science ®Google Scholar
• Higgins V, Ma L, Ragosnig BL, et al. Analytical performance and quality indicators of fully automated immunoassays for sFlt-1 and PlGF. J Appl Lab Med. 2022;7(2):555–567. doi: 10.1093/jalm/jfab135.
   PubMedGoogle Scholar
• Law LW, Sahota DS, Chan LW, et al. Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women. J Matern Fetal Neonatal Med. 2010;23(12):1475–1480. doi: 10.3109/14767051003678242.
   PubMed Web of Science ®Google Scholar
• Thiers RE, Wu GT, Reed AH, et al. Sample stability: a suggested definition and method of determination. Clin Chem. 1976;22(2):176–183. doi: 10.1093/clinchem/22.2.176.
   PubMed Web of Science ®Google Scholar
• Åsberg A, Solem KB, Mikkelsen G. Prøvematerialets holdbarhet – kriterier og vurderinger. Klinisk Biokemi i Norden. 2011;23:34–38.
   Google Scholar
• Braga F, Ferraro S, Borille S, et al. Biological variation of two serum markers for preeclampsia prediction. Clin Chem Lab Med. 2020;58(2):e27–e28. doi: 10.1515/cclm-2019-0649.
   PubMed Web of Science ®Google Scholar
• Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet. 2005;365(9469):1500–1505. doi: 10.1016/S0140-6736(05)66422-7.
   PubMed Web of Science ®Google Scholar